{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:50:20Z","timestamp":1777297820448,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.therap.2025.02.011","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:11:23Z","timestamp":1741115483000},"page":"647-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analyse de la d\u00e9claration de pharmacovigilance par les chirurgiens-dentistes en France\u00a0: bilan des 10\u00a0derni\u00e8res ann\u00e9es"],"prefix":"10.1016","volume":"80","author":[{"given":"Antonin","family":"Vagnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Peyrouzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoryia","family":"Prontskus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Guihard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Vettoretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Blanche Valnet","family":"Rabier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2025.02.011_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3917\/spub.131.0069","article-title":"Pharmacovigilance chez les chirurgiens-dentistes\u00a0: enqu\u00eate dans la r\u00e9gion de Dakar, S\u00e9n\u00e9gal","volume":"25","author":"Diouf","year":"2013","journal-title":"Sante Publique"},{"key":"10.1016\/j.therap.2025.02.011_bib0070","unstructured":"L\u00e9gifrance. Article L5121-1\u00a0\u2013\u00a0Code de la sant\u00e9 publique. 2023. https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000044628485 [Consult\u00e9 le 3\u00a0mars 2025]."},{"key":"10.1016\/j.therap.2025.02.011_bib0075","unstructured":"Legifrance. Article R5121-150\u00a0\u2013\u00a0Code de la sant\u00e9 publique. 2021. https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000043761864 [Consult\u00e9 le 3\u00a0mars 2025]."},{"key":"10.1016\/j.therap.2025.02.011_bib0080","first-page":"427","article-title":"Organisation et int\u00e9r\u00eat de la pharmacovigilance","volume":"2","author":"Lebrun-Vignes","year":"2022","journal-title":"FMC Ann Dermatol Venereol"},{"key":"10.1016\/j.therap.2025.02.011_bib0085","unstructured":"ANSM. Bonnes pratiques de pharmacovigilance 2022. https:\/\/ansm.sante.fr\/documents\/reference\/bonnes-pratiques-de-pharmacovigilance [Consult\u00e9 le 3\u00a0mars 2025]."},{"key":"10.1016\/j.therap.2025.02.011_bib0090","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/jcpt.13219","article-title":"Tooth loss associated with the use of tenofovir disoproxil fumarate","volume":"45","author":"Jianfei","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.therap.2025.02.011_bib0095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/14740338.2023.2247962","article-title":"Sublingual\/buccal buprenorphine and dental problems: a pharmacovigilance study","volume":"22","author":"Barus","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.therap.2025.02.011_bib0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/odi.13218","article-title":"Oral immune-related adverse events associated with PD-1\u00a0inhibitor therapy: a case series","volume":"26","author":"Shazib","year":"2020","journal-title":"Oral Dis"},{"key":"10.1016\/j.therap.2025.02.011_bib0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/jpgm.jpgm_1059_21","article-title":"Levetiracetam-induced gingival hyperplasia","volume":"68","author":"James","year":"2022","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.therap.2025.02.011_bib0110","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40120-024-00616-7","article-title":"Dental adverse effects of anti-CD20\u00a0therapies","volume":"13","author":"Bartak","year":"2024","journal-title":"Neurol Ther"},{"key":"10.1016\/j.therap.2025.02.011_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bjoms.2019.09.023","article-title":"Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-\u03b1) inhibitors: a systematic review","volume":"58","author":"Sacco","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.therap.2025.02.011_bib0060","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.3390\/ijerph17249509","article-title":"Medication-related osteonecrosis of the jaws and CDK4\/6\u00a0inhibitors: a recent association","volume":"17","author":"Marcian\u00f2","year":"2020","journal-title":"Int J Environ Res Public Health"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:20:59Z","timestamp":1776446459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595725000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0040595725000393"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2025.02.011","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyse de la d\u00e9claration de pharmacovigilance par les chirurgiens-dentistes en France\u00a0: bilan des 10\u00a0derni\u00e8res ann\u00e9es","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2025.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}